Sep 22, 2026 11 0
Uploaded by Levi
Favorite
Share
More Options
20
Trastuzumab deruxtecan in - HER2-expressing gynecologic cancers from DESTINY-PanTumor02 - antitumor activity, safety, and exploratory biomarker analyses_Page 1

Open in WPS to view all 20 pages